Table 4 Univariate and multivariate analyses for all patients who underwent surgery
Variable | Univariate Model | Multivariate Model | ||||
|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Age, years | ||||||
  < 60 | REF |  |  |  |  |  |
  ≥ 60 | 1.016 | 0.423–2.438 | 0.885 |  |  |  |
BMI, kg/m | ||||||
 <25 | REF |  |  |  |  |  |
  ≥ 25 | 0.621 | 0.286–1.349 | 0.228 |  |  |  |
Sex | ||||||
 Female | REF |  |  |  |  |  |
 Male | 1.067 | 0.443–2.566 | 0.885 |  |  |  |
IL-6(pg/mL) | ||||||
  ≤ 108 | REF |  |  | REF |  |  |
 >108 | 33.662 | 11.906–95.178 | <0.001 | 24.937 | 6.837–90.931 | <0.001 |
D-dimer (ug/mL) | ||||||
  ≤ 14.0 | REF |  |  | REF |  |  |
 >14.0 | 24.706 | 8.884–68.705 | <0.001 | 18.757 | 5.094–69.075 | <0.001 |
PT (sec) | ||||||
  ≤ 15.0 | REF |  |  | REF |  |  |
  > 15.0 | 2.667 | 1.12–6.346 | 0.027 | 1.198 | 0.268–5.350 | 0.813 |
Heamoglobin (10ˆ9/L) | ||||||
  ≤ 10 | REF |  |  |  |  |  |
 >10 | 0.979 | 0.419–2.285 | 0.961 |  |  |  |
Neutrophile granulocyte (10ˆ9/L) | ||||||
  ≤ 7.0 | REF |  |  |  |  |  |
 >7.0 | 0.942 | 0.361–2.456 | 0.942 |  |  |  |
Leukomonocyte (10ˆ9/L) | ||||||
  ≤ 0.8 | REF |  |  |  |  |  |
 >0.8 | 0.545 | 0.241–1.235 | 0.146 |  |  |  |
Hemoglobin (g/L) | ||||||
  ≥ 120 | REF |  |  |  |  |  |
 <120 | 0.77 | 0.326–1.820 | 0.552 |  |  |  |
Albumin (g/L) | ||||||
  ≥ 35.0 | REF |  |  |  |  |  |
 <35.0 | 0.565 | 0.256–1.427 | 0.157 |  |  |  |
Troponin-I (ug/L) | ||||||
  ≤ 0.02 | REF |  |  |  |  |  |
 >0.02 | 1.229 | 0.568–2.662 | 0.601 |  |  |  |
NT-ProBNP (pg/mL) | ||||||
  ≤ 349 | REF |  |  |  |  |  |
 >349 | 1.442 | 0.663–3.135 | 0.356 |  |  |  |
Serum creatinine (umol/L) | ||||||
  ≤ 135 | REF |  |  | REF |  |  |
 >135 | 2.365 | 0.982–5.696 | 0.055 | 1.965 | 0.493–7.829 | 0.338 |
Lactic acid (mmol/L) | ||||||
  ≤ 2.5 | REF |  |  |  |  |  |
 >2.5 | 2.287 | 0.735–7.116 | 0.153 |  |  |  |
Alanine aminotransferase (IU/L) | ||||||
  ≤ 40 | REF |  |  |  |  |  |
 >40 | 0.650 | 0.285–1.483 | 0.306 |  |  |  |
Aspartate aminotransferase (IU/L) | ||||||
  ≤ 46 | REF |  |  |  |  |  |
 >46 | 0.605 | 0.258–1.415 | 0.246 |  |  |  |
EF (%) | ||||||
  ≥ 60.0 | REF |  |  |  |  |  |
 <60.0 | 1.128 | 0.431–2.954 | 0.807 |  |  |  |
Marfan Syndrome | ||||||
 no | REF |  |  |  |  |  |
 yes | 1.275 | 0.236–6.891 | 0.778 |  |  |  |
Hypertension | ||||||
 no | REF |  |  |  |  |  |
 yes | 2.469 | 0.505–12.080 | 0.265 |  |  |  |
Diabetes | ||||||
 no | REF |  |  |  |  |  |
 yes | 0.33 | 0.040–2.703 | 0.302 |  |  |  |
Pericardial effusion (Medium or above) | ||||||
 no | REF |  |  |  |  |  |
 yes | 3.281 | 0.444–24.234 | 0.244 |  |  |  |
MPS | ||||||
 no | REF |  |  |  |  |  |
 yes | 1.877 | 0.583–6.043 | 0.291 |  |  |  |
AR (Medium or above) | ||||||
 no | REF |  |  |  |  |  |
 yes | 0.731 | 0.287–1.866 |  |  |  |  |
History of cardiac surgery | ||||||
 no | REF |  |  |  |  |  |
 yes | 1.65 | 0.464–5.863 | 0.439 |  |  |  |
Operative time (min) | ||||||
  ≤ 306 | REF |  |  | REF |  |  |
 >306 | 1.962 | 0.899–4.279 | 0.09 | 3.635 | 0.977–13.521 | 0.054 |
CPB time (min) | ||||||
  ≤ 149 | REF |  |  |  |  |  |
 >149 | 0.894 | 0.409–1.952 | 0.779 |  |  |  |
Aortic Clamp time (min) | ||||||
  ≤ 51 | REF |  |  |  |  |  |
 >51 | 1.324 | 0.601–2.920 | 0.486 |  |  |  |
SBP time (min) | ||||||
  ≤ 9.7 | REF |  |  |  |  |  |
 >9.7 | 1.037 | 0.468–2.296 | 0.929 |  |  |  |
CA time (min) | ||||||
  ≤ 3.1 | REF |  |  |  |  |  |
 >3.1 | 1.121 | 0.489–2.568 | 0.787 |  |  |  |
Aortic Root Concomitant procedure | ||||||
 no | REF |  |  |  |  |  |
 yes | 0.659 | 0.294–1.478 | 0.312 |  |  |  |